메뉴 건너뛰기
Journal of the Pakistan Medical Association
Volumn 64, Issue 9, 2014, Pages 1090-1093
Hypoglycaemia in diabetes
Author keywords

Diabetes management; Hypoglycaemia
Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; SEDATIVE AGENT; SULFONYLUREA; TERBUTALINE; ANTIDIABETIC AGENT;
EID: 84907318641     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)
References (9)
  • 1
    • 18144388647 scopus 로고    scopus 로고
    • Defining and reporting hypoglycemia in diabetes
    • American Diabetes Association Workgroup on Hypoglycemia
    • American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005; 28: 1245-9.
    • (2005) Diabetes Care , vol.28 , pp. 1245-1249
  • 3
    • 80052615073 scopus 로고    scopus 로고
    • Medically minimizing the impact of hypoglycemia in type 2 diabetes: A review
    • Noh RM, Graveling AJ, Frier BM. Medically minimizing the impact of hypoglycemia in type 2 diabetes: a review. Expert Opin Pharmacother 2011; 12: 2161-75.
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 2161-2175
    • Noh, R.M.1    Graveling, A.J.2    Frier, B.M.3
  • 4
    • 84873179268 scopus 로고    scopus 로고
    • Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: Results from OBSTACLE Hypoglycemia Study
    • Kalra S, Deepak MC, Narang P, Singh V, Uvaraj MG, Agrawal N. Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycemia Study. Diabetes Technol Ther 2013; 15: 129-35.
    • (2013) Diabetes Technol Ther , vol.15 , pp. 129-135
    • Kalra, S.1    Deepak, M.C.2    Narang, P.3    Singh, V.4    Uvaraj, M.G.5    Agrawal, N.6
  • 5
    • 79955931729 scopus 로고    scopus 로고
    • Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management
    • Dejager S, Schweizer A. Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management. Diabetes Ther 2011; 2: 51-66.
    • (2011) Diabetes Ther , vol.2 , pp. 51-66
    • Dejager, S.1    Schweizer, A.2
  • 6
    • 62749102585 scopus 로고    scopus 로고
    • Effects of intensive therapy and antecedent hypoglycemia on counter regulatory responses to hypoglycemia in type 2 diabetes
    • Davis SN, Mann S, Briscoe VJ, Ertl AC, Tate DB. Effects of intensive therapy and antecedent hypoglycemia on counter regulatory responses to hypoglycemia in type 2 diabetes. Diabetes 2009; 58: 701-9.
    • (2009) Diabetes , vol.58 , pp. 701-709
    • Davis, S.N.1    Mann, S.2    Briscoe, V.J.3    Ertl, A.C.4    Tate, D.B.5
  • 7
    • 84907371111 scopus 로고    scopus 로고
    • Managing diabetes during fasting - A focus on Buddhist Lent
    • Latt TS, Kalra S. Managing diabetes during fasting - A focus on Buddhist Lent. Diabetes Voice 2012; 57: 42-5.
    • (2012) Diabetes Voice , vol.57 , pp. 42-45
    • Latt, T.S.1    Kalra, S.2
  • 8
    • 84868235205 scopus 로고    scopus 로고
    • Treatment of severe diabetic hypoglycemia with glucagon: An underutilized therapeutic approach
    • Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes 2011; 4: 337-46.
    • (2011) Diabetes Metab Syndr Obes , vol.4 , pp. 337-346
    • Kedia, N.1
  • 9
    • 79953737150 scopus 로고    scopus 로고
    • Hypoglycaemia: Current management and controversies
    • Choudhary P, Amiel SA. Hypoglycaemia: current management and controversies. Postgrad Med J 2011; 87: 298-306.
    • (2011) Postgrad Med J , vol.87 , pp. 298-306
    • Choudhary, P.1    Amiel, S.A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.